Downregulated CXCL12 expression in mesenchymal stem cells associated with severe aplastic anemia in children
详细信息 查看全文
- 作者：Yu-Hua Chao (1) (2) (3)
Kang-Hsi Wu (4) (5)
Shiow-Her Chiou (6)
Shu-Fen Chiang (6)
Chih-Yang Huang (6)
Hsiu-Ching Yang (7)
Chin-Kan Chan (8)
Ching-Tien Peng (4) (5) (9)
Han-Ping Wu (10)
Kuan-Chih Chow (7)
Maw-Sheng Lee (1) (11)
1. Institute of Medicine ; Chung Shan Medical University ; No. 110 ; Sec. 1 ; Chien-Kuo N. Road ; Taichung ; 402 ; Taiwan
2. Department of Pediatrics ; Chung Shan Medical University Hospital ; Taichung ; Taiwan
3. School of Medicine ; Chung Shan Medical University ; Taichung ; Taiwan
4. Department of Hemato-oncology ; Children鈥檚 Hospital ; China Medical University Hospital ; China Medical University ; Taichung ; Taiwan
5. School of Chinese Medicine ; China Medical University ; Taichung ; Taiwan
6. Graduate Institute of Microbiology and Public Health ; National Chung Hsing University ; Taichung ; Taiwan
7. Graduate Institute of Biomedical Sciences ; National Chung Hsing University ; No. 250 ; Kuo-Kuang Road ; Taichung ; 40227 ; Taiwan
8. Department of Pediatrics ; Taoyuan General Hospital ; Taoyuan ; Taiwan
9. Department of Biotechnology and Bioinformatics ; Asia University ; Taichung ; Taiwan
10. Department of Pediatrics ; Buddhist Tzu-Chi General Hospital ; Taichung Branch ; Taichung ; Taiwan
11. Department of Obstetrics and Gynecology ; Chung Shan Medical University Hospital ; Taichung ; Taiwan - 关键词：Aplastic anemia ; Bone marrow failure ; CXCL12 ; Gene expression ; Mesenchymal stem cells
- 刊名：Annals of Hematology
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：94
- 期：1
- 页码：13-22
- 全文大小：4,649 KB
- 参考文献：1. Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, Laporte J-R, Catalan Group for Study of Agranulocytosis and Aplastic Anemia (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 93:518鈥?23 CrossRef
2. Davies JK, Guinan EC (2007) An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol 136:549鈥?64 CrossRef
3. Kurre P, Johnson FL, Deeg HJ (2005) Diagnosis and treatment of children with aplastic anemia. Pediatr Blood Cancer 45:770鈥?80 CrossRef
4. Lazennec G, Jorgensen C (2008) Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 26:1387鈥?394 7-1006" target="_blank" title="It opens in new window">CrossRef
5. Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 36:1035鈥?046 CrossRef
6. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875鈥?84 72X(00)00482-3" target="_blank" title="It opens in new window">CrossRef
7. Verfaillie CM (1993) Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82:2045鈥?053
8. Gordon MY (1988) Extracellular matrix of the marrow microenvironment. Br J Haematol 70:1鈥? CrossRef
9. Chao YH, Wu HP, Chan CK, Tsai C, Peng CT, Wu KH (2012) Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation. J Biomed Biotechnol 2012:759503
10. Wu KH, Sheu JN, Wu HP, Tsai C, Sieber M, Peng CT, Chao YH (2013) Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Transplantation 95:773鈥?77 7/TP.0b013e31827a93dd" target="_blank" title="It opens in new window">CrossRef
11. Xu Y, Takahashi Y, Wang Y, Hama A, Nishio N, Muramatsu H, Tanaka M, Yoshida N, Villalobos IB, Yagasaki H, Kojima S, Xu Y, Takahashi Y, Wang Y, Hama A, Nishio N, Muramatsu H, Tanaka M, Yoshida N, Villalobos IB, Yagasaki H, Kojima S (2009) Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia. Exp Hematol 37:1393鈥?399 CrossRef
12. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B (1994) Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 84:3685鈥?690
13. Bacigalupo A, Valle M, Podesta M, Pitto A, Zocchi E, De Flora A, Pozzi S, Luchetti S, Frassoni F, Van Lint MT, Piaggio G (2005) T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 33:819鈥?27 CrossRef
14. Hotta T, Kato T, Maeda H, Yamao H, Yamada H, Saito H (1985) Functional changes in marrow stromal cells in aplastic anaemia. Acta Haematol 74:65鈥?9 71" target="_blank" title="It opens in new window">CrossRef
15. Wu X, Li Y, Zhu K, Wang Z, Chen S, Yang L (2007) GATA-1, 鈭? and 鈭? genes expression in bone marrow microenviroment with chronic aplastic anemia. Hematology 12:331鈥?35 701255288" target="_blank" title="It opens in new window">CrossRef
16. Li J, Yang S, Lu S, Zhao H, Feng J, Li W, Ma F, Ren Q, Liu B, Zhang L, Zheng Y, Han ZC (2012) Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia. PLoS ONE 7:e47764 71/journal.pone.0047764" target="_blank" title="It opens in new window">CrossRef
17. Chao YH, Tsai C, Peng CT, Wu HP, Chan CK, Weng T, Wu KH (2011) Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplant 46:1391鈥?392 CrossRef
18. Chao YH, Peng CT, Harn HJ, Chan CK, Wu KH (2010) Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann Hematol 89:715鈥?23 7/s00277-009-0892-6" target="_blank" title="It opens in new window">CrossRef
19. Chan CK, Wu KH, Lee YS, Hwang SM, Lee MS, Liao SK, Cheng EH, See LC, Tsai CN, Kuo ML, Huang JL (2012) The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs. Transplantation 94:132鈥?38 7/TP.0b013e31825940a4" target="_blank" title="It opens in new window">CrossRef
20. Wu KH, Chan CK, Tsai C, Chang YH, Sieber M, Chiu TH, Ho M, Peng CT, Wu HP, Huang JL (2011) Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 91:1412鈥?416 7/TP.0b013e31821aba18" target="_blank" title="It opens in new window">CrossRef
21. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11鈥?0 76.x" target="_blank" title="It opens in new window">CrossRef
22. Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18:207鈥?08 7" target="_blank" title="It opens in new window">CrossRef
23. Harris MA, Clark J, Ireland A et al (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258鈥揇261 CrossRef
24. Sutton JF, Stacey M, Kearns WG, Rieg TS, Young NS, Liu JM (2004) Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes. Pediatr Blood Cancer 42:122鈥?26 79" target="_blank" title="It opens in new window">CrossRef
25. Fuhrer M, Durner J, Brunnler G, Gotte H, Deppner C, Bender-Gotze C, Albert E (2007) HLA association is different in children and adults with severe acquired aplastic anemia. Pediatr Blood Cancer 48:186鈥?91 785" target="_blank" title="It opens in new window">CrossRef
26. Watt SM, Forde SP (2008) The central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders? Vox Sang 94:18鈥?2
27. Mishima S, Nagai A, Abdullah S, Matsuda C, Taketani T, Kumakura S, Shibata H, Ishikura H, Kim SU, Masuda J (2010) Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent. Eur J Haematol 84:538鈥?46 CrossRef
28. Nie Y, Han YC, Zou YR (2008) CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 205:777鈥?83 72513" target="_blank" title="It opens in new window">CrossRef
29. Lataillade JJ, Clay D, Bourin P, Herodin F, Dupuy C, Jasmin C, Le Bousse-Kerdiles MC (2002) Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99:1117鈥?129 7" target="_blank" title="It opens in new window">CrossRef
30. Broxmeyer HE, Kohli L, Kim CH, Lee Y, Mantel C, Cooper S, Hangoc G, Shaheen M, Li X, Clapp DW (2003) Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukocyte Biol 73:630鈥?38 CrossRef
31. Tzeng YS, Li H, Kang YL, Chen WC, Cheng WC, Lai DM (2011) Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression. Blood 117:429鈥?39 CrossRef
32. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635鈥?38 CrossRef
33. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95:9448鈥?453 73/pnas.95.16.9448" target="_blank" title="It opens in new window">CrossRef
34. Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977鈥?88 CrossRef
35. Kiel MJ, Morrison SJ (2006) Maintaining hematopoietic stem cells in the vascular niche. Immunity 25:862鈥?64 CrossRef
36. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque JP, Chappel J, Ross FP, Link DC (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106:3020鈥?027 72" target="_blank" title="It opens in new window">CrossRef
37. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687鈥?94 CrossRef
38. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829鈥?34 CrossRef
39. Schajnovitz A, Itkin T, D'Uva G, Kalinkovich A, Golan K, Ludin A, Cohen D, Shulman Z, Avigdor A, Nagler A, Kollet O, Seger R, Lapidot T (2011) CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nat Immunol 12:391鈥?98 7" target="_blank" title="It opens in new window">CrossRef
40. Marquez-Curtis LA, Janowska-Wieczorek A (2013) Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. BioMed Res Int 2013:561098 CrossRef
41. Bobis-Wozowicz S, Miekus K, Wybieralska E, Jarocha D, Zawisz A, Madeja Z, Majka M (2011) Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Exp Hematol 39:686鈥?96 CrossRef
42. Cao Z, Zhang G, Wang F, Liu H, Liu L, Han Y, Zhang J, Yuan J (2013) Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS ONE 8:e82949 71/journal.pone.0082949" target="_blank" title="It opens in new window">CrossRef
43. Chen W, Li M, Li Z, Yan Z, Cheng H, Pan B, Cao J, Chen C, Zeng L, Xu K (2012) CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. Immunol Lett 143:161鈥?69 CrossRef
44. Zaim M, Karaman S, Cetin G, Isik S (2012) Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol 91:1175鈥?186 7/s00277-012-1438-x" target="_blank" title="It opens in new window">CrossRef - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Hematology
Oncology - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-0584
文摘
The mechanisms of idiopathic severe aplastic anemia (SAA) in children are not completely understood. Insufficiency of the bone marrow microenvironment, in which mesenchymal stem cells (MSCs) are an important element, can be a potential factor associated with hematopoietic impairment. In the current study, we studied whether aberrant gene expression could be found in MSCs from children with SAA. Using microarray analysis, two different patterns of global gene expression were detected in the SAA MSCs. Fourteen genes (POLE2, HGF, KIF20A, TK1, IL18R1, KITLG, FGF18, RRM2, TTK, CXCL12, DLG7, TOP2A, NUF2, and TYMS), which are related to DNA synthesis, cytokines, or growth factors, were significantly downregulated. Further, knockdown of gene expression was performed using the small hairpin RNA (shRNA)-containing lentivirus method. We found that knockdown of CXCL12, HGF, IL-18R1, FGF18, or RRM2 expression compelled MSCs from the controls to behave like those from the SAA children, with decreased survival and differentiation potential. Among them, inhibition of CXCL12 gene expression had the most profound effects on the behavior of MSCs. Further experiments regarding re-introduction of the CXCL12 gene could largely recover the survival and differentiation potential in MSCs with inhibition of CXCL12 expression. Our findings suggest that MSCs from children with SAA exhibit aberrant gene expression profiles and downregulation of CXCL12 gene may be associated with alterations in the bone marrow microenvironment.